Oracle (ORCL) PT Raised to $115 at Morgan Stanley, 'outstanding uncertainties surrounding installed base'

Morgan Stanley analyst Keith Weiss raised the price target on Oracle (NYSE: ORCL) to $115.00 (from $106.00) while maintaining a Equalweight rating.

The analyst comments " Despite potential opportunities surrounding OCI, existing database customers and cloud-based ERP applications, questions remain surrounding the path for forward EPS growth with the Cerner acquisition and slowing pace of share repurchases. While incrementally more positive on the trajectory of top-line growth at Oracle, given outstanding uncertainties surrounding installed base migration and margins, we remain Equal-weight with a price target of $115."

You May Also Be Interested In

• Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
• Morgan Stanley Assumes Moncler SpA (MONC:IM) (MONRY) at Equalweight
• TD Cowen Starts Nkarta Inc. (NKTX) at Buy